Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Flavia Matovu-Kiweewa"'
Autor:
Rita Nakalega, Nelson Mukiza, George Kiwanuka, Ronald Makanga-Kakumba, Robert Menge, Hajira Kataike, Joel Maena, Carolyne Akello, Patience Atuhaire, Flavia Matovu-Kiweewa, Cynthia Ndikuno-Kuteesa, Henry Debem, Andrew Mujugira
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background Viral load (VL) testing is the gold-standard approach for monitoring human immunodeficiency virus (HIV) treatment success and virologic failure, but uptake is suboptimal in resource-limited and rural settings. We conducted a cross
Externí odkaz:
https://doaj.org/article/db2d0bd781ce45998995128bf1b0b081
Autor:
Bashir Ssuna, Anne Katahoire, Mari Armstrong-Hough, Dennis Kalibbala, Joan N. Kalyango, Flavia Matovu Kiweewa
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background The World Health Organization (WHO) recommends the use of pre-exposure prophylaxis (PrEP) in key populations at elevated risk for exposure to HIV. If used effectively, PrEP can reduce annual HIV incidence to below 0.05%. However,
Externí odkaz:
https://doaj.org/article/d68ffb7a8cd44aa4ad66aa47bae69030
Autor:
Morgan Garcia, Ellen Luecke, Ashley J. Mayo, Rachel Scheckter, Patrick Ndase, Flavia Matovu Kiweewa, Doreen Kemigisha, Petina Musara, Leila E. Mansoor, Nishanta Singh, Kubashni Woeber, Neetha S. Morar, Nitesha Jeenarain, Zakir Gaffoor, Daniel K. Gondwe, Yvonne Makala, Llewellyn Fleurs, Krishnaveni Reddy, Thesla Palanee-Phillips, Jared M. Baeten, Ariane van der Straten, Lydia Soto-Torres, Kristine Torjesen
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Low adherence to investigational products can negatively impact study outcomes, limiting the ability to demonstrate efficacy. To continue advancing potential new HIV prevention technologies, efforts are needed to improve adherence
Externí odkaz:
https://doaj.org/article/c42e11a6e8a640d9b0d026c07dfa4e70
Autor:
Hellen Musana, Jude Thaddeus Ssensamba, Mary Nakafeero, Henry Mugerwa, Flavia Matovu Kiweewa, David Serwadda, Francis Ssali
Publikováno v:
AIDS Research and Therapy, Vol 18, Iss 1, Pp 1-10 (2021)
Abstract Introduction Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries
Externí odkaz:
https://doaj.org/article/548f59b63fc64cc7af01b5bcf601f05b
Autor:
Lillian Tugume, Timothy Ronald Muwonge, Edith Nakku Joloba, John Bosco Isunju, Flavia Matovu Kiweewa
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Acceptability of Pre-exposure Prophylaxis (PrEP) could be hampered by low self-perceived risk for HIV acquisition. Moreover, discordance between risk perception and actual risk of HIV acquisition is likely to occur. We assessed co
Externí odkaz:
https://doaj.org/article/f49d44b86b0d40da82759dcff048c73b
Autor:
Llewellyn Fleurs, Lydia Soto-Torres, Jared M. Baeten, Flavia Matovu Kiweewa, Patrick Ndase, Petina Musara, Ashley J Mayo, Nishanta Singh, Thesla Palanee-Phillips, Zakir Gaffoor, Daniel K. Gondwe, Morgan Garcia, Yvonne Makala, Krishnaveni Reddy, Neetha S. Morar, Nitesha Jeenarain, Leila E. Mansoor, Ellen Luecke, Doreen Kemigisha, Rachel Scheckter, Kubashni Woeber, Ariane van der Straten, Kristine Torjesen
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Public Health
BMC Public Health
Background Low adherence to investigational products can negatively impact study outcomes, limiting the ability to demonstrate efficacy. To continue advancing potential new HIV prevention technologies, efforts are needed to improve adherence among st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e5db983d6014bdb3c973342d864bce
https://doaj.org/article/c42e11a6e8a640d9b0d026c07dfa4e70
https://doaj.org/article/c42e11a6e8a640d9b0d026c07dfa4e70
Autor:
Stephanie Cox, Alexander Kintu, Yongwu Shao, Flavia Matovu Kiweewa, Zubair M Lukyamuzi, Francis Kiweewa, Shelley N Facente, Eduard Grebe, Ramin Ebrahimi, Christoph C Carter, Christian Callebaut, Jared Baeten, Moupali Das
Publikováno v:
Open Forum Infectious Diseases. 9
Background HIV-1 recent infection testing algorithms (RITAs) use recency assays to estimate population level HIV incidence rates (IRs), and are currently being employed in PrEP trials to estimate background HIV incidence rates (bHIV-IR). The SIENA st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b25b4e0235c020c7c4a921f00beec368
https://doi.org/10.1093/ofid/ofac492.1701
https://doi.org/10.1093/ofid/ofac492.1701
Autor:
Flavia Matovu Kiweewa, Aspire Study Team, Marla Husnik, Thesla Palanee-Phillips, Zakir Gaffoor, Ariane van der Straten, Leila E. Mansoor, Samantha Siva, Sufia Dadabhai, Devika Singh, Nitesha Jeenarain, Brenda Gati Mirembe, Elizabeth R. Brown, Edward Livant, Jared M. Baeten, Lydia Soto-Torres
Publikováno v:
AIDS Behav
Understanding characteristics associated with adherence to pre-exposure prophylaxis (PrEP) methods for HIV-1 prevention may assist with optimizing implementation efforts. The dapivirine vaginal ring is a novel topical PrEP delivery method. Using data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad907dbda869a1b9531024523688a2e
https://doi.org/10.1007/s10461-021-03231-x
https://doi.org/10.1007/s10461-021-03231-x
Autor:
Jared M. Baeten, Flavia Matovu Kiweewa, Mtn, Kathryn Peebles, Aspire Study Team, Doerieyah Reynolds, Nitesha Jeenarain, Devika Singh, Catherine A. Chappell, Sharon L. Hillier, Thesla Palanee-Phillips, Bonus Makanani, Katherine E. Bunge, Jennifer E. Balkus, Elizabeth R. Brown, Logashvari Naidoo
Publikováno v:
Clin Infect Dis
Background Limited evidence suggests that the nonhormonal contraceptive copper intrauterine device (Cu-IUD) may increase bacterial vaginosis (BV) risk, possibly due to increased volume and duration of menses, a common side effect of Cu-IUD use. Altho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba10c109bf7e90c46fa5d1f2f7486a1c
https://doi.org/10.1093/cid/ciaa703
https://doi.org/10.1093/cid/ciaa703
Autor:
Aspire, Katherine E. Bunge, Cliff Kelly, Mtn, Jeanne M. Marrazzo, Flavia Matovu Kiweewa, Zvavahera M. Chirenje, Krishnaveni Reddy, Elizabeth R. Brown, Gonasagrie Nair, Samantha Siva, Voice Study Teams, Nitesha Jeenarain, Nyaradzo Mgodi, Bonus Makanani, Lameck Chinula, Logashvari Naidoo, Linda-Gail Bekker, Lydia Soto-Torres, Thesla Palanee-Phillips, Jeanna M. Piper, Jared M. Baeten
Publikováno v:
AIDS
Objective We aimed to determine if the dapivirine vaginal ring and the ring device alone (flexible silicone matrix polymer) was associated with the development of cervical cytology abnormalities. Design Secondary analysis comparing cervical cytology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f033824c1aac61c0f915d5ec38722d8b
https://doi.org/10.1097/qad.0000000000002451
https://doi.org/10.1097/qad.0000000000002451